DailyDoctor Archive Specialties Get app
Back to the 12 September 2026 edition

Research · 02 of 06

Ribbon-type pseudodrusen with soft drusen marked the retina that lost sensitivity fastest

Record the pseudodrusen subtype alongside soft drusen when you image intermediate macular degeneration - the combination of ribbon-type and soft drusen marked the retina losing sensitivity fastest.

Design
retrospective longitudinal cohort with point-level microperimetry and linear mixed-effects modelling
Population
46 eyes of 28 patients with intermediate age-related macular degeneration or reticular pseudodrusen, imaged twice 6-12 months apart
Primary outcome
baseline retinal sensitivity and its change, by drusen composition at each of 37 test points
Effect
ribbon-type pseudodrusen 0.72 ± 0.24 dB lower than lesion-free retina (P=0.002), dot-type no difference (P=0.120); greatest decline where ribbon-type and soft drusen coexisted (interaction P=0.005)

Reticular pseudodrusen are a known risk marker in intermediate age-related macular degeneration, but they are treated as one entity. This study tested whether the subtype matters, using microperimetry at two timepoints six to twelve months apart in 46 eyes of 28 patients, and classifying pseudodrusen presence and subtype - dot or ribbon - and soft drusen separately at each of 37 grid test points on co-registered multimodal imaging.

At baseline, retina carrying ribbon-type pseudodrusen had lower sensitivity than lesion-free retina (mean difference 0.72 ± 0.24 dB, P=0.002), while dot-type showed no difference (P=0.120). Soft drusen were independently associated with reduced sensitivity (P=0.021), with no interaction at baseline. Over follow-up the interaction appeared and was the main finding (P=0.005): regions with both ribbon-type pseudodrusen and soft drusen declined fastest, while in the absence of soft drusen the pseudodrusen subtypes behaved identically.

This is a point-level analysis in 46 eyes with a single follow-up interval, and 0.72 dB is a small difference on a measure with meaningful test-retest variability. It is not a reason to reclassify anyone. What it does suggest is that the pseudodrusen phenotype, which most reports collapse into a yes or no, carries information about which retina is functionally at risk - and that the combination with soft drusen, not either lesion alone, is what marks it. If that survives replication, it belongs in how these eyes are followed rather than in what they are called.

  • Record reticular pseudodrusen subtype when reporting multimodal imaging in intermediate macular degeneration, not just their presence
  • Note the combination that mattered: ribbon-type pseudodrusen coexisting with soft drusen
  • Do not change follow-up intervals on this alone - 46 eyes and one follow-up interval is not enough
  • Remember a 0.72 dB microperimetry difference sits close to test-retest variability for the technique
  • Keep the established counselling: intermediate macular degeneration with pseudodrusen is higher risk regardless of subtype

Why it matters

It suggests the lesion phenotype we record as a binary is carrying functional risk information we are discarding.

Don't overread it

Forty-six eyes with a single follow-up interval of six to twelve months - this is hypothesis-generating and needs replication before it changes surveillance.

The statistics, in plain English

Test points within an eye and eyes within a patient are not independent observations, which is why linear mixed-effects models were used - but 46 eyes from 28 patients is a small base for a three-way structure. A baseline difference of 0.72 dB with a standard error of 0.24 is statistically clear and clinically slight, given that microperimetry test-retest variability is typically of similar magnitude. The longitudinal interaction (P=0.005) is the more interesting result and also the more fragile, since interactions need far more data than main effects to estimate reliably.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

retinaglaucoma

Tomorrow morning, before your first patient

One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app